Investment Q&A

Q: last up date was in summer. this stock has flat lined. yd 4% but no growth. (in fact looks like sliding back. my purchase price $10 july 2015. feel i should move on. any suggestions?

Q: Can you please comment or provide any opinion on ATE phase2 trials for their ATB-346 drug? my understanding is that results of liver tests in test patients have provided mixed results from the trials. Also please provide forecast for share price going forward based on potential drug trial success? I know they have been obtaining private funds and i believe GUD has 10 or 20% stake in ATE. thanks

Q: Are there any Canadian listed companies that are producing and/or refining cobalt that you might feel comfortable recommending? Have you any info on csk? Thanx

Q: What are your thoughts on company at this time

Q: Second Cup is now just a pale comparison of itself. Do you think there is a chance of a turnaround here?

Q: Please comment on their earnings release.

Q: Hi Peter, Ryan and team,

I have a quick regarding Colabor Group. Is it a turn around story worth investing. Will the dividend come back. What is the business model and is the debt manageable. Is the company for a stable and organic growth or high growth potential. Thank you in advance.

Norwood

Q: I think Aquila has been raising money by selling shares which were over-subscribed. It looks like insiders have purchased 24% of the issued shares. Finder's fees (cash and warrants) have been awarded to company insiders I suppose. Certainly there has been share dilution but surely dilution is preferable to borrowing money against non-existant cash flow. I know the stock is high risk but my exposure is very low - less than 0.1%.
2 questions...
Does everything still look OK to 5i?
Does Hudbay own any part of the Back-Fourty target?
Thanks
Jim

Q: Hello!

They announced another piece of business today. Looking at starting a position here. What would be a reasonable timeframe to wait for a price increase (turnaround). Would you consider it a good buy?

Thanks!

Q: Hi,
I am down 60% on this this one. Very small portion of my portfolio (less than 1%. Just wondering if I should average down or let it be for now. Stock looks pretty cheap on P/E, P/B and P/S. RFC went down with the oil and gas sector because of its large exposure to Alberta. RFC seems to be doing ok. Do you think this is dead money or does it have some potential in the medium term.

Q: Hi Peter,
GPS reports after the close today.
Do you think the first quarter will be as good as Q4.
Thanks

Q: Hi folks,can please opinion on Q results for Redknee rkn/t and guidance going forward. Looks to be another miss and company withdrawing guidance for rest of 2017. Is there any hope for Redknee or just sell at loss and move on, thanks as always, jb

Q: Hi, Greenspace Brands seems to be receiving favourable coverage recently with several BNN guests liking it. The trend and tilt towards organic food is certainly growing specially the millenials and others with better affordability. What are the growth metrics for this company, acquisitions and organic? You had mentioned that stock is already expensive and there does n't seem to be much coverage among analysts, except one I noticed from Raymond James. company did a financing at $1.20 in December, 2016. Stock already trading at $1.67 and most gains made in last 2 weeks. Is it worth taking a small position, before it catches world's attention ? Premium Brands, also in food business, although not an identical co. but was n't discovered by retail investors when it was trading at a fraction of today's price just 3 years ago. Will appreciate your thoughts. Thanks

Q: Do you have an opinion on the earnings prospects and present valuation for this co?

Q: Your opinion on WiLan's results please ? For those of us still hanging on would you still consider this a hold ?

Q: input capital took a big dip today, any idea why?

Q: I realize this company (GSE Systems, GVP-US) may not be covered by you in the normal course of events but it was mentioned by a BNN analyst and sounded very interesting. Do you know anything about it?

Q: Just as a follow up to the answer you gave on this company, IRD was highlighted by Ryan Irvine in his monthly Keystock newsletter of Feb 1, 2017. As well, the year end numbers will be issued the last week of February and there may be buyers ahead of the report.

Q: What is your thoughts about the results and outlook for Sangoma? The stock looks cheap for a Company with $25 million in sales which is expected to grow 15-20%?

Q: I have a half position in this company for some time, do you think it is still a good buy at this price. I really like what this company does, and the last 2 weeks it has really shot up, with no news, on large volume. Any idea why this is taking off.
Thank you once again for the great service.